We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
-6.52%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.4M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow
% of AUM
114.43%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
184
New
184
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$12.9M |
| 2 |
Rithm Capital
RITM
|
+$4.16M |
| 3 |
GSK
GSK
|
+$2.65M |
| 4 |
Sanofi
SNY
|
+$2.47M |
| 5 |
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
|
+$2.41M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.93% |
| 2 | Real Estate | 12% |
| 3 | Financials | 8.32% |
| 4 | Technology | 3.45% |
| 5 | Industrials | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elanco Animal Health
ELAN
$12.7B
| $962K | 0.99% |
+77,500
| New | +$1.35M |
|
27
Intuitive Surgical
ISRG
$125B
| $937K | 0.96% |
+5,000
| New | +$1.07M |
|
|
MOR
28
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $931K | 0.96% |
+185,000
| New | +$956K |
|
29
Aveanna Healthcare
AVAH
$2.12B
| $900K | 0.92% |
+600,000
| New | +$1.23M |
|
30
Stereotaxis
STXS
$150M
| $900K | 0.92% |
+500,000
| New | +$1.07M |
|
31
Enact Holdings
ACT
$6.46B
| $898K | 0.92% |
+40,512
| New | +$971K |
|
32
BioCryst Pharmaceuticals
BCRX
$2.36B
| $882K | 0.91% |
+70,000
| New | +$901K |
|
33
Omnicell
OMCL
$2.05B
| $870K | 0.89% |
+10,000
| New | +$1.05M |
|
34
Vuzix
VUZI
$194M
| $869K | 0.89% |
+150,000
| New | +$1.16M |
|
35
Ametek
AME
$53.9B
| $851K | 0.87% |
+7,500
| New | +$899K |
|
|
ADAM
36
Adamas Trust
ADAM
$796M
| $848K | 0.87% |
+90,585
| New | +$1.03M |
|
|
FSTX
37
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $845K | 0.87% |
+165,000
| New | +$1.04M |
|
38
Gilead Sciences
GILD
$166B
| $833K | 0.85% |
+13,500
| New | +$851K |
|
|
ONIT
39
Onity Group
ONIT
$336M
| $829K | 0.85% |
+35,618
| New | +$1.03M |
|
40
Innoviva
INVA
$1.58B
| $789K | 0.81% |
+68,000
| New | +$932K |
|
41
Embecta
EMBC
$200M
| $777K | 0.8% |
+27,000
| New | +$799K |
|
|
RWT
42
Redwood Trust
RWT
$630M
| $754K | 0.77% |
+131,398
| New | +$1.02M |
|
|
TARO
43
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $735K | 0.75% |
+24,500
| New | +$845K |
|
44
Accuray
ARAY
$30.2M
| $728K | 0.75% |
+350,000
| New | +$796K |
|
45
Viridian Therapeutics
VRDN
$2.09B
| $728K | 0.75% |
+35,500
| New | +$638K |
|
46
Welltower
WELL
$172B
| $711K | 0.73% |
+11,059
| New | +$864K |
|
47
Bio-Rad Laboratories Class A
BIO
$8.18B
| $709K | 0.73% |
+1,700
| New | +$848K |
|
48
MGIC Investment
MTG
$6.19B
| $691K | 0.71% |
+53,900
| New | +$755K |
|
49
AirSculpt Technologies
AIRS
$327M
| $688K | 0.71% |
+107,000
| New | +$860K |
|
|
SLGC
50
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $660K | 0.68% |
+227,500
| New | +$958K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q3 2022 Portfolio in Review
Q3 2022 is the first quarter with a 13F filing on record for AlphaCentric Advisors, which disclosed 184 positions worth $97.4M. Its ten largest holdings account for 33% of the portfolio.
Its largest position is iShares 1-3 Year Treasury Bond ETF: 157,224 shares worth $12.8M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, followed by Real Estate and Financials.
- AlphaCentric Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 157,224 shares worth $12.8M.
- AlphaCentric Advisors's ten largest holdings make up 33% of its $97.4M portfolio in Q3 2022.
- AlphaCentric Advisors disclosed 184 positions in Q3 2022, its first 13F filing on record.
Based on AlphaCentric Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.